Saundra Pelletier ^Leaders

Saundra Pelletier is the CEO of Evofem Biosciences, where she has successfully led the company through significant growth and its transition to the public market, raising over $500 million in equity financing. Under her leadership, Evofem launched Phexxi, the first hormone-free, on-demand prescription birth control approved in the U.S., and expanded its product offerings with the acquisition of Solosec, an FDA-approved treatment for common sexual health infections. With a robust background in womens health, Saundra has held key positions at various organizations, including serving as a director at Windtree Therapeutics and TRACON Pharmaceuticals, and as a member of the Women Corporate Directors Foundation. She is also an accomplished author, contributing to publications such as Forbes and Medium, where she shares insights on womens health and leadership. Saundra holds a Bachelor of Science in Business Administration from Husson University and has been recognized as one of the Top 50 Most Influential Women Over 50 by the San Diego Business Journal. Her commitment to advancing womens health and social responsibility is further exemplified through her advisory roles with organizations like Susan G. Komen and the Center for Community Solutions.